Catalyst

Slingshot members are tracking this event:

Akili Labs (PTCHF) Begins Enrollment for STARS-ADHD Trial Evaluating Software Treatment EVO in Actively Reducing the Severity of Attention Deficit Hyperactive Disorder (ADHD) in Children

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PTCHF

100%
Akili Interactive Labs

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 06, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Trial Enrollment, Initiation, Stars-adhd, Evo, Attention Deficit Hyperactive Disorder, Adhd, Software Treatment